Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of infliximab on inflammatory and fibrous lesions in intestinal Crohn's disease
2006-004784-58Phase 4Completed
- Sponsor
- KU Leuven
- Start
- Apr 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, single-arm trial of infliximab in Crohn's disease, sponsored by KU Leuven. Started Apr 2007; status: completed.
02
Drugs
infliximab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2006-004784-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004784-58.